Cell & Molecular Technologies Inc.

Cell & Molecular Technologies, Inc. (CMT) provides responsive, creative, state-of-the-art contract research and development services using cost and time effective approaches to the pharmaceutical, biotechnology, and biomedical research communities. CMT can augment your research program with an experienced staff that provides innovative thinking and competence in molecular biology, cell biology, biochemistry, bio-processing, mouse genetics, and assay development. We combine our staff scientists' expertise, drawn from their extensive experience at leading industrial and academic research institutions, with the cutting-edge knowledge of our network of academic scientists and consultants, to deliver sophisticated and flexible research services. We approach contract research and development through close collaboration and communication with the client's scientists in the design and execution of projects.

CMT offers a broad range of services to assist you in your basic research and drug discovery programs. Since its beginning in 1993, CMT has served world- renowned pharmaceutical and biotechnology companies. CMT conducts contract research for clients on a simple fee-for-service basis. Our relationship with the client is completely confidential and highly collaborative. Regular communications keep the client well informed of the data and progress of a project, and enable discussions to evaluate results and experimental direction.

CMT has the ability to address both conceptual and experimental problems in gene cloning, expression, and function, and to devise novel approaches to elusive experimental problems.

The Specialty Media Division of CMT (formerly Specialty Media, Inc.) develops, manufactures, and markets high-quality research products, providing custom-formulated cell culture media, products for gene transfer and expression, and media and reagents for serum-free cell culture, mouse embryo culture, and mouse embryonic stem cells. The Specialty Media Division also identifies and develops research products derived from CMT's internal research activities.